| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |